mHealth app for rural women lowers risk of low birth weight, improves prenatal outcomes

In a study published in Telemedicine and e-Health, researchers tested the effectiveness of mobile health applications to improve early and ongoing prenatal care through engagement.

The study focused on pregnant women in rural areas of Wyoming with little access to prenatal care. Researchers aimed to show the benefits of using the WYhealth Due Date Plus pregnancy application. Pregnant Medicaid patients were used in the study where 85 registered for the app and 5,158 were assigned to the control group. Data was collected on how many times participants used the app, C-section rates, low birth weights and admission into the neonatal intensive care unit. These factors were used to analyze the association of app usages to birth outcomes.

Results showed that the app was downloaded 1,730 times, and users of the app had significant association with completion of their six month or more prenatal visit. The app was also shown in association with lowered risk of a baby with a low birth weight.

“Preliminary data indicate that Due Date Plus attracted an engaged user base and that app usage was associated with improvements in prenatal visit completion and reduced incidence of low-birth weight delivery,” concluded James Bush, MD, first author on the study and colleagues. “These promising results suggest broader implementation and further study of mobile applications for prenatal support.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup